Intrinsic Value of S&P & Nasdaq Contact Us

Talphera, Inc. TLPH NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
57/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Talphera, Inc. (TLPH) has a negative trailing P/E of -2.4, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 83.1 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -41.16%, forward earnings yield 1.20%. PEG 0.03 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (100/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.03).
  • Forward P/E 83.1 — analysts expect a return to profitability with estimated EPS of $0.01 for FY2029.
  • PEG Ratio 0.03 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield -41.16% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 1.20% as earnings recover.

Overall SharesGrow Score: 57/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
57/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
50/100
→ Income
GROWTH
15/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — TLPH

Valuation Multiples
P/E (TTM)-2.4
Forward P/E83.1
PEG Ratio0.03
Forward PEG0.03
P/B Ratio2.04
P/S Ratio599.82
EV/EBITDA-1.5
Per Share Data
EPS (TTM)$-0.34
Forward EPS (Est.)$0.01
Book Value / Share$0.40
Revenue / Share$0.00
FCF / Share$-0.27
Yields & Fair Value
Earnings Yield-41.16%
Forward Earnings Yield1.20%
Dividend Yield0.00%

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -2.7 -0.05 -22.07 6.79 -
2017 -1.9 -0.12 -2.63 12.02 -
2018 -2.9 0.11 31.72 62.73 -
2019 -3.1 0.19 -4.03 72.99 -
2020 -2.6 0.09 -1.90 19.52 -
2021 -1.9 0.05 -1.87 177.57 -
2022 0.4 0.00 0.77 0.00 -
2023 -0.6 0.00 0.75 16.21 -
2024 -1.0 0.02 1.69 0.00 -
2025 -3.4 0.11 2.84 1,726.72 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-19.05 $17.36M $-43.16M -248.6%
2017 $-21.97 $8M $-51.51M -644.3%
2018 $-16.14 $2.15M $-47.15M -2192%
2019 $-13.45 $2.29M $-53.24M -2325.9%
2020 $-9.47 $5.42M $-40.38M -745.6%
2021 $-5.86 $2.82M $-35.1M -1245.5%
2022 $5.72 $1.77M $47.76M 2696.5%
2023 $-1.29 $651K $-18.4M -2826%
2024 $-0.50 $0.00 $-13M -
2025 $-0.34 $28K $-14.29M -51035.7%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.31 $-0.31 – $-0.31 $3.95M $3.95M – $3.95M 1
2027 $-0.26 $-0.33 – $-0.20 $5.59M $5.59M – $5.59M 2
2028 $-0.18 $-0.31 – $-0.05 $10.76M $10.76M – $10.76M 2
2029 $0.01 $0.01 – $0.01 $23.56M $23.56M – $23.56M 1
2030 $0.26 $0.26 – $0.26 $48.31M $48.31M – $48.31M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message